Budesonide Sprays
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Budesonide Aerosol Market Research Report 2024
1 Budesonide Aerosol Market Overview
1.1 Product Overview and Scope of Budesonide Aerosol
1.2 Budesonide Aerosol Segment by Type
1.2.1 Global Budesonide Aerosol Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 50ug/200 Spray
1.2.3 100ug/200 Spray
1.2.4 200ug/100 Spray
1.2.5 Other
1.3 Budesonide Aerosol Segment by Application
1.3.1 Global Budesonide Aerosol Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Budesonide Aerosol Market Size Estimates and Forecasts
1.4.1 Global Budesonide Aerosol Revenue 2017-2028
1.4.2 Global Budesonide Aerosol Sales 2017-2028
1.4.3 Budesonide Aerosol Market Size by Region: 2017 Versus 2021 Versus 2028
2 Budesonide Aerosol Market Competition by Manufacturers
2.1 Global Budesonide Aerosol Sales Market Share by Manufacturers (2017-2022)
2.2 Global Budesonide Aerosol Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Budesonide Aerosol Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Budesonide Aerosol Manufacturing Sites, Area Served, Product Type
2.5 Budesonide Aerosol Market Competitive Situation and Trends
2.5.1 Budesonide Aerosol Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Budesonide Aerosol Players Market Share by Revenue
2.5.3 Global Budesonide Aerosol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Budesonide Aerosol Retrospective Market Scenario by Region
3.1 Global Budesonide Aerosol Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Budesonide Aerosol Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Budesonide Aerosol Market Facts & Figures by Country
3.3.1 North America Budesonide Aerosol Sales by Country
3.3.2 North America Budesonide Aerosol Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Budesonide Aerosol Market Facts & Figures by Country
3.4.1 Europe Budesonide Aerosol Sales by Country
3.4.2 Europe Budesonide Aerosol Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Budesonide Aerosol Market Facts & Figures by Region
3.5.1 Asia Pacific Budesonide Aerosol Sales by Region
3.5.2 Asia Pacific Budesonide Aerosol Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Budesonide Aerosol Market Facts & Figures by Country
3.6.1 Latin America Budesonide Aerosol Sales by Country
3.6.2 Latin America Budesonide Aerosol Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Budesonide Aerosol Market Facts & Figures by Country
3.7.1 Middle East and Africa Budesonide Aerosol Sales by Country
3.7.2 Middle East and Africa Budesonide Aerosol Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Budesonide Aerosol Historic Market Analysis by Type
4.1 Global Budesonide Aerosol Sales Market Share by Type (2017-2022)
4.2 Global Budesonide Aerosol Revenue Market Share by Type (2017-2022)
4.3 Global Budesonide Aerosol Price by Type (2017-2022)
5 Global Budesonide Aerosol Historic Market Analysis by Application
5.1 Global Budesonide Aerosol Sales Market Share by Application (2017-2022)
5.2 Global Budesonide Aerosol Revenue Market Share by Application (2017-2022)
5.3 Global Budesonide Aerosol Price by Application (2017-2022)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.1.4 AstraZeneca Budesonide Aerosol Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Pfizer Budesonide Aerosol Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Teva Budesonide Aerosol Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Cipla Budesonide Aerosol Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Novartis Budesonide Aerosol Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Mylan Budesonide Aerosol Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Abbott Budesonide Aerosol Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Takeda
6.8.1 Takeda Corporation Information
6.8.2 Takeda Description and Business Overview
6.8.3 Takeda Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Takeda Budesonide Aerosol Product Portfolio
6.8.5 Takeda Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Boehringer Ingelheim Budesonide Aerosol Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Allgen Pharmaceuticals
6.10.1 Allgen Pharmaceuticals Corporation Information
6.10.2 Allgen Pharmaceuticals Description and Business Overview
6.10.3 Allgen Pharmaceuticals Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Allgen Pharmaceuticals Budesonide Aerosol Product Portfolio
6.10.5 Allgen Pharmaceuticals Recent Developments/Updates
6.11 Squibb
6.11.1 Squibb Corporation Information
6.11.2 Squibb Budesonide Aerosol Description and Business Overview
6.11.3 Squibb Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Squibb Budesonide Aerosol Product Portfolio
6.11.5 Squibb Recent Developments/Updates
6.12 Sandoz
6.12.1 Sandoz Corporation Information
6.12.2 Sandoz Budesonide Aerosol Description and Business Overview
6.12.3 Sandoz Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Sandoz Budesonide Aerosol Product Portfolio
6.12.5 Sandoz Recent Developments/Updates
6.13 Shimadzu Corp
6.13.1 Shimadzu Corp Corporation Information
6.13.2 Shimadzu Corp Budesonide Aerosol Description and Business Overview
6.13.3 Shimadzu Corp Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Shimadzu Corp Budesonide Aerosol Product Portfolio
6.13.5 Shimadzu Corp Recent Developments/Updates
6.14 Manus Aktteva Biopharma LLP
6.14.1 Manus Aktteva Biopharma LLP Corporation Information
6.14.2 Manus Aktteva Biopharma LLP Budesonide Aerosol Description and Business Overview
6.14.3 Manus Aktteva Biopharma LLP Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Manus Aktteva Biopharma LLP Budesonide Aerosol Product Portfolio
6.14.5 Manus Aktteva Biopharma LLP Recent Developments/Updates
6.15 Skyepharma
6.15.1 Skyepharma Corporation Information
6.15.2 Skyepharma Budesonide Aerosol Description and Business Overview
6.15.3 Skyepharma Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Skyepharma Budesonide Aerosol Product Portfolio
6.15.5 Skyepharma Recent Developments/Updates
6.16 Shanghai Sine Pharmaceutical
6.16.1 Shanghai Sine Pharmaceutical Corporation Information
6.16.2 Shanghai Sine Pharmaceutical Budesonide Aerosol Description and Business Overview
6.16.3 Shanghai Sine Pharmaceutical Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Shanghai Sine Pharmaceutical Budesonide Aerosol Product Portfolio
6.16.5 Shanghai Sine Pharmaceutical Recent Developments/Updates
6.17 Lunan Better Pharmaceutical
6.17.1 Lunan Better Pharmaceutical Corporation Information
6.17.2 Lunan Better Pharmaceutical Budesonide Aerosol Description and Business Overview
6.17.3 Lunan Better Pharmaceutical Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Lunan Better Pharmaceutical Budesonide Aerosol Product Portfolio
6.17.5 Lunan Better Pharmaceutical Recent Developments/Updates
6.18 Wellcome Australia Ltd
6.18.1 Wellcome Australia Ltd Corporation Information
6.18.2 Wellcome Australia Ltd Budesonide Aerosol Description and Business Overview
6.18.3 Wellcome Australia Ltd Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Wellcome Australia Ltd Budesonide Aerosol Product Portfolio
6.18.5 Wellcome Australia Ltd Recent Developments/Updates
6.19 Synmosa Biopharma Corporation
6.19.1 Synmosa Biopharma Corporation Corporation Information
6.19.2 Synmosa Biopharma Corporation Budesonide Aerosol Description and Business Overview
6.19.3 Synmosa Biopharma Corporation Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Synmosa Biopharma Corporation Budesonide Aerosol Product Portfolio
6.19.5 Synmosa Biopharma Corporation Recent Developments/Updates
6.20 Chiesi Farmaceutici S.p.A
6.20.1 Chiesi Farmaceutici S.p.A Corporation Information
6.20.2 Chiesi Farmaceutici S.p.A Budesonide Aerosol Description and Business Overview
6.20.3 Chiesi Farmaceutici S.p.A Budesonide Aerosol Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Chiesi Farmaceutici S.p.A Budesonide Aerosol Product Portfolio
6.20.5 Chiesi Farmaceutici S.p.A Recent Developments/Updates
7 Budesonide Aerosol Manufacturing Cost Analysis
7.1 Budesonide Aerosol Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Budesonide Aerosol
7.4 Budesonide Aerosol Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Budesonide Aerosol Distributors List
8.3 Budesonide Aerosol Customers
9 Budesonide Aerosol Market Dynamics
9.1 Budesonide Aerosol Industry Trends
9.2 Budesonide Aerosol Market Drivers
9.3 Budesonide Aerosol Market Challenges
9.4 Budesonide Aerosol Market Restraints
10 Global Market Forecast
10.1 Budesonide Aerosol Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Budesonide Aerosol by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Budesonide Aerosol by Type (2023-2028)
10.2 Budesonide Aerosol Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Budesonide Aerosol by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Budesonide Aerosol by Application (2023-2028)
10.3 Budesonide Aerosol Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Budesonide Aerosol by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Budesonide Aerosol by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Budesonide Aerosol Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
Table 2. Global Budesonide Aerosol Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
Table 3. Global Budesonide Aerosol Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Budesonide Aerosol Market Competitive Situation by Manufacturers in 2021
Table 5. Global Budesonide Aerosol Sales (K Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Budesonide Aerosol Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Budesonide Aerosol Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Budesonide Aerosol Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Budesonide Aerosol Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Budesonide Aerosol Manufacturing Sites and Area Served
Table 11. Manufacturers Budesonide Aerosol Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Budesonide Aerosol by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Budesonide Aerosol as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Budesonide Aerosol Sales by Region (2017-2022) & (K Pcs)
Table 16. Global Budesonide Aerosol Sales Market Share by Region (2017-2022)
Table 17. Global Budesonide Aerosol Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Budesonide Aerosol Revenue Market Share by Region (2017-2022)
Table 19. North America Budesonide Aerosol Sales by Country (2017-2022) & (K Pcs)
Table 20. North America Budesonide Aerosol Sales Market Share by Country (2017-2022)
Table 21. North America Budesonide Aerosol Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Budesonide Aerosol Revenue Market Share by Country (2017-2022)
Table 23. Europe Budesonide Aerosol Sales by Country (2017-2022) & (K Pcs)
Table 24. Europe Budesonide Aerosol Sales Market Share by Country (2017-2022)
Table 25. Europe Budesonide Aerosol Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Budesonide Aerosol Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Budesonide Aerosol Sales by Region (2017-2022) & (K Pcs)
Table 28. Asia Pacific Budesonide Aerosol Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Budesonide Aerosol Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Budesonide Aerosol Revenue Market Share by Region (2017-2022)
Table 31. Latin America Budesonide Aerosol Sales by Country (2017-2022) & (K Pcs)
Table 32. Latin America Budesonide Aerosol Sales Market Share by Country (2017-2022)
Table 33. Latin America Budesonide Aerosol Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Budesonide Aerosol Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Budesonide Aerosol Sales by Country (2017-2022) & (K Pcs)
Table 36. Middle East and Africa Budesonide Aerosol Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Budesonide Aerosol Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Budesonide Aerosol Revenue Market Share by Country (2017-2022)
Table 39. Global Budesonide Aerosol Sales by Type (2017-2022) & (K Pcs)
Table 40. Global Budesonide Aerosol Sales Market Share by Type (2017-2022)
Table 41. Global Budesonide Aerosol Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Budesonide Aerosol Revenue Share by Type (2017-2022)
Table 43. Global Budesonide Aerosol Price by Type (2017-2022) & (USD/Pcs)
Table 44. Global Budesonide Aerosol Sales (K Pcs) by Application (2017-2022)
Table 45. Global Budesonide Aerosol Sales Market Share by Application (2017-2022)
Table 46. Global Budesonide Aerosol Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Budesonide Aerosol Revenue Share by Application (2017-2022)
Table 48. Global Budesonide Aerosol Price by Application (2017-2022) & (USD/Pcs)
Table 49. AstraZeneca Corporation Information
Table 50. AstraZeneca Description and Business Overview
Table 51. AstraZeneca Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 52. AstraZeneca Budesonide Aerosol Product
Table 53. AstraZeneca Recent Developments/Updates
Table 54. Pfizer Corporation Information
Table 55. Pfizer Description and Business Overview
Table 56. Pfizer Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 57. Pfizer Budesonide Aerosol Product
Table 58. Pfizer Recent Developments/Updates
Table 59. Teva Corporation Information
Table 60. Teva Description and Business Overview
Table 61. Teva Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 62. Teva Budesonide Aerosol Product
Table 63. Teva Recent Developments/Updates
Table 64. Cipla Corporation Information
Table 65. Cipla Description and Business Overview
Table 66. Cipla Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 67. Cipla Budesonide Aerosol Product
Table 68. Cipla Recent Developments/Updates
Table 69. Novartis Corporation Information
Table 70. Novartis Description and Business Overview
Table 71. Novartis Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 72. Novartis Budesonide Aerosol Product
Table 73. Novartis Recent Developments/Updates
Table 74. Mylan Corporation Information
Table 75. Mylan Description and Business Overview
Table 76. Mylan Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 77. Mylan Budesonide Aerosol Product
Table 78. Mylan Recent Developments/Updates
Table 79. Abbott Corporation Information
Table 80. Abbott Description and Business Overview
Table 81. Abbott Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 82. Abbott Budesonide Aerosol Product
Table 83. Abbott Recent Developments/Updates
Table 84. Takeda Corporation Information
Table 85. Takeda Description and Business Overview
Table 86. Takeda Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 87. Takeda Budesonide Aerosol Product
Table 88. Takeda Recent Developments/Updates
Table 89. Boehringer Ingelheim Corporation Information
Table 90. Boehringer Ingelheim Description and Business Overview
Table 91. Boehringer Ingelheim Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 92. Boehringer Ingelheim Budesonide Aerosol Product
Table 93. Boehringer Ingelheim Recent Developments/Updates
Table 94. Allgen Pharmaceuticals Corporation Information
Table 95. Allgen Pharmaceuticals Description and Business Overview
Table 96. Allgen Pharmaceuticals Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 97. Allgen Pharmaceuticals Budesonide Aerosol Product
Table 98. Allgen Pharmaceuticals Recent Developments/Updates
Table 99. Squibb Corporation Information
Table 100. Squibb Description and Business Overview
Table 101. Squibb Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 102. Squibb Budesonide Aerosol Product
Table 103. Squibb Recent Developments/Updates
Table 104. Sandoz Corporation Information
Table 105. Sandoz Description and Business Overview
Table 106. Sandoz Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 107. Sandoz Budesonide Aerosol Product
Table 108. Sandoz Recent Developments/Updates
Table 109. Shimadzu Corp Corporation Information
Table 110. Shimadzu Corp Description and Business Overview
Table 111. Shimadzu Corp Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. Shimadzu Corp Budesonide Aerosol Product
Table 113. Shimadzu Corp Recent Developments/Updates
Table 114. Manus Aktteva Biopharma LLP Corporation Information
Table 115. Manus Aktteva Biopharma LLP Description and Business Overview
Table 116. Manus Aktteva Biopharma LLP Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. Manus Aktteva Biopharma LLP Budesonide Aerosol Product
Table 118. Manus Aktteva Biopharma LLP Recent Developments/Updates
Table 119. Skyepharma Corporation Information
Table 120. Skyepharma Description and Business Overview
Table 121. Skyepharma Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 122. Skyepharma Budesonide Aerosol Product
Table 123. Skyepharma Recent Developments/Updates
Table 124. Shanghai Sine Pharmaceutical Corporation Information
Table 125. Shanghai Sine Pharmaceutical Description and Business Overview
Table 126. Shanghai Sine Pharmaceutical Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 127. Shanghai Sine Pharmaceutical Budesonide Aerosol Product
Table 128. Shanghai Sine Pharmaceutical Recent Developments/Updates
Table 129. Lunan Better Pharmaceutical Corporation Information
Table 130. Lunan Better Pharmaceutical Description and Business Overview
Table 131. Lunan Better Pharmaceutical Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 132. Lunan Better Pharmaceutical Budesonide Aerosol Product
Table 133. Lunan Better Pharmaceutical Recent Developments/Updates
Table 134. Wellcome Australia Ltd Corporation Information
Table 135. Wellcome Australia Ltd Description and Business Overview
Table 136. Wellcome Australia Ltd Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 137. Wellcome Australia Ltd Budesonide Aerosol Product
Table 138. Wellcome Australia Ltd Recent Developments/Updates
Table 139. Synmosa Biopharma Corporation Corporation Information
Table 140. Synmosa Biopharma Corporation Description and Business Overview
Table 141. Synmosa Biopharma Corporation Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 142. Synmosa Biopharma Corporation Budesonide Aerosol Product
Table 143. Synmosa Biopharma Corporation Recent Developments/Updates
Table 144. Chiesi Farmaceutici S.p.A Corporation Information
Table 145. Chiesi Farmaceutici S.p.A Description and Business Overview
Table 146. Chiesi Farmaceutici S.p.A Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 147. Chiesi Farmaceutici S.p.A Budesonide Aerosol Product
Table 148. Chiesi Farmaceutici S.p.A Recent Developments/Updates
Table 149. Production Base and Market Concentration Rate of Raw Material
Table 150. Key Suppliers of Raw Materials
Table 151. Budesonide Aerosol Distributors List
Table 152. Budesonide Aerosol Customers List
Table 153. Budesonide Aerosol Market Trends
Table 154. Budesonide Aerosol Market Drivers
Table 155. Budesonide Aerosol Market Challenges
Table 156. Budesonide Aerosol Market Restraints
Table 157. Global Budesonide Aerosol Sales Forecast by Type (2023-2028) & (K Pcs)
Table 158. Global Budesonide Aerosol Sales Market Share Forecast by Type (2023-2028)
Table 159. Global Budesonide Aerosol Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 160. Global Budesonide Aerosol Revenue Market Share Forecast by Type (2023-2028)
Table 161. Global Budesonide Aerosol Sales Forecast by Application (2023-2028) & (K Pcs)
Table 162. Global Budesonide Aerosol Sales Market Share Forecast by Application (2023-2028)
Table 163. Global Budesonide Aerosol Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 164. Global Budesonide Aerosol Revenue Market Share Forecast by Application (2023-2028)
Table 165. Global Budesonide Aerosol Sales Forecast by Region (2023-2028) & (K Pcs)
Table 166. Global Budesonide Aerosol Sales Market Share Forecast by Region (2023-2028)
Table 167. Global Budesonide Aerosol Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 168. Global Budesonide Aerosol Revenue Market Share Forecast by Region (2023-2028)
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Budesonide Aerosol
Figure 2. Global Budesonide Aerosol Market Share by Type in 2021 & 2028
Figure 3. 50ug/200 Spray Product Picture
Figure 4. 100ug/200 Spray Product Picture
Figure 5. 200ug/100 Spray Product Picture
Figure 6. Other Product Picture
Figure 7. Global Budesonide Aerosol Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Other
Figure 11. Global Budesonide Aerosol Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Budesonide Aerosol Market Size (2017-2028) & (US$ Million)
Figure 13. Global Budesonide Aerosol Sales (2017-2028) & (K Pcs)
Figure 14. Budesonide Aerosol Sales Share by Manufacturers in 2021
Figure 15. Global Budesonide Aerosol Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Budesonide Aerosol Players: Market Share by Revenue in 2021
Figure 17. Budesonide Aerosol Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Budesonide Aerosol Sales Market Share by Region (2017-2022)
Figure 19. Global Budesonide Aerosol Sales Market Share by Region in 2021
Figure 20. Global Budesonide Aerosol Revenue Market Share by Region (2017-2022)
Figure 21. Global Budesonide Aerosol Revenue Market Share by Region in 2021
Figure 22. U.S. Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Budesonide Aerosol Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Budesonide Aerosol by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Budesonide Aerosol
Figure 46. Manufacturing Process Analysis of Budesonide Aerosol
Figure 47. Budesonide Aerosol Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca Pfizer Teva Cipla Novartis Mylan Abbott Takeda Boehringer Ingelheim Allgen Pharmaceuticals Squibb Sandoz Shimadzu Corp Manus Aktteva Biopharma LLP Skyepharma Shanghai Sine Pharmaceutical Lunan Better Pharmaceutical Wellcome Australia Ltd Synmosa Biopharma Corporation Chiesi Farmaceutici S.p.A